INDIA IPO
  • Home
  • About
    • About us
    • Our CSR
  • Services

    IPO

    • Initial Public Offering (IPO)
    • SME IPO Consultation
    • Mainline IPO Consultation
    • Follow-On Public Offer (FPO)
    • Pre-IPO Funding Consultants

    Capital Raising

    • Social Stock Exchange
    • Private Placement
    • Project Funding
    • REIT
    • SM REIT
    • Rights Issue Advisory
    • InvIT Rights Issue
    • InvIT Public Issue
    • InvIT Private Issue
    • Debt Syndication
    • Securitised Debt Instruments
    • Public Municipal Debt
    • Private Municipal Debt

    Finance Advisory

    • Business Valuation
    • Corporate Finance
    • Financial Modelling
    • Project Finance
  • Investors
  • Merchant Bankers

    SME

    • List of SME Merchant Bankers

    MAINBOARD

    • List of Mainboard Merchant Bankers
  • Resources

    Reports

    • Daily Reporter
    • IPO Calendar
    • Mainline IPO Report
    • SME IPO Report
    • SME IPOs by Sector
    • Mainboard IPOs by Sector

    IPO Knowledge

    • IPO World Magazine
    • IPO Process
    • Pre-IPO Process Guidance
    • IPO Blogs
    • Sector Wise IPO List In India
    • List of IPO Registrar

    Notifications / Circulars

    • BSE SME Eligibility Criteria
    • SEBI ICDR Amendment Regulations March 2025
    • SEBI SME IPO ICDR Amendments report Mar–Nov 2025
    • NSE Emerge Eligibility Criteria
    • ICDR
  • News/Updates
    • Markets & Money Update
    • IPO & Market Snaps
  • Contact Us
  • Check IPO Feasibility
Check IPO Feasibility
INDIA IPO
INDIA IPO

Contact Info:

  • +91-96506-37280
  • +011-47008280
  • info@indiaipo.in
  • 808, 8thFloor D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034.
shape
  1. Home
  2. News
  3. ICRA Analytics Limited Recommends Dividend of Rs. 54 Per Equity Share, Total Payout at Rs. 53.7 Crores
ipo services in India
India IPO
  • 18 May 2026
  • X
 ICRA Analytics Limited Recommends Dividend of Rs. 54 Per Equity Share, Total Payout at Rs. 53.7 Crores

ICRA Analytics Limited, a wholly owned material subsidiary of ICRA Limited, has recommended a dividend of Rs. 54 per equity share of face value Rs. 10 each at its Board of Directors meeting held on May 18, 2026. The total recommended dividend amounts to Rs. 53.7 crores. The disclosure was made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and was communicated to both BSE Limited and the National Stock Exchange of India Limited by the Company Secretary & Compliance Officer.

ICRA Analytics Limited Recommends Dividend of Rs. 54 Per Equity Share, Total Payout at Rs. 53.7 Crores

ICRA Limited has informed the stock exchanges of a significant corporate development at its wholly owned material subsidiary, ICRA Analytics Limited. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company disclosed that the Board of Directors of ICRA Analytics Limited, in its meeting held on May 18, 2026, has recommended a dividend on equity shares.

Dividend Recommendation Details

The Board of Directors of ICRA Analytics Limited recommended a dividend of Rs. 54 per equity share. The equity shares carry a face value of Rs. 10 each. The total recommended dividend works out to Rs. 53.7 crores. The key parameters of this dividend recommendation are summarised below:

Parameter: Details Dividend Per Equity Share: Rs. 54 Face Value Per Share: Rs. 10 Total Recommended Dividend: Rs. 53.7 crores Board Meeting Date: May 18, 2026 Regulatory Disclosure: Regulation 30, SEBI (LODR) Regulations, 2015 Subsidiary Type: Wholly Owned Material Subsidiary

Regulatory Disclosure

The disclosure was made in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The communication was signed by S. Shakeb Rahman, Company Secretary & Compliance Officer of ICRA Limited, and submitted to both BSE Limited and the National Stock Exchange of India Limited on May 18, 2026.

ICRA Limited has notified the stock exchanges of an upcoming Board of Directors meeting, scheduled for Thursday, May 21, 2026. The intimation was filed on May 5, 2026, pursuant to Regulation 29 and other applicable regulations of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended.

Board Meeting Agenda

The board meeting has been convened to address key financial and corporate governance matters for the financial year 2025-26. The following items are on the agenda:

Agenda Item: Details Financial Results (Standalone): Audited results for the quarter and year ended March 31, 2026 Financial Results (Consolidated): Audited results for the quarter and year ended March 31, 2026 Dividend Consideration: Recommendation of dividend, if any, on equity shares for FY 2025-26 Meeting Date: Thursday, May 21, 2026

Regulatory Compliance

The intimation has been issued in accordance with Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The filing was signed by S. Shakeb Rahman, Company Secretary & Compliance Officer of ICRA Limited, and submitted to both BSE Limited and the National Stock Exchange of India Limited.

ICRA Limited is headquartered at Building No. 8, 2nd Floor, Tower A, DLF Cyber City, Phase II, Gurugram - 122002, Haryana, with its registered office at B - 710, Statesman House, 148, Barakhamba Road, New Delhi - 110001.

We’re building Scanx - to help you express your trading & investing idea, to help you analyse the markets better.

Stock Markets are the true indicator of the growth of any country's economy. We are bullish on India, we are bullish on India's prospects to be one of largest economies of the world. We believe that Stock Markets provide an unique opportunity for all Indians to participate in the growth story of India. We are enabling the same for Indians.

As financial services are becoming more accessible, there is now a large set of Indians today who are financially aware and literate. They value time and seek high quality products & services. Most screening, trading, investing platforms available today are more or less similar to each other, and they have not evolved with time. While both traders & investors have gotten smart about how they make money and build wealth, as users they have continued to use the same products, features, and platforms that were available for years with little or no innovation.

We plan to change that - a technology-led and artificial intelligence enabled platform built for super traders and long term investors.

Disclaimer:

The data and information provided on this website is for general informational and research purposes only. While we strive to ensure that the content is accurate, up-to-date, and reliable, this platform utilizes artificial intelligence (AI) tools to generate, curate, and summarize information. As such, the content may occasionally contain errors, omissions, or outdated information. All users are therefore advised to cross verify the source of the data and information.

This website does not constitute professional, legal, financial, medical, or any other form of licensed advice. Users are encouraged to independently verify any information before relying on it, especially for decisions that may have legal, financial, or personal consequences.

The views, analyses, and summaries presented on this platform may be generated or assisted by AI and do not necessarily reflect the opinions of the website owners, operators, editors, or affiliates.

We make no warranties or representations, express or implied, regarding the completeness, accuracy, reliability, suitability, or availability of the information contained on this website. Any reliance you place on such information is strictly at your own risk.

This website may include links to third-party sources or content. We do not control or endorse the nature, accuracy, or availability of those external sites and are not responsible for any content or damages arising from their use.

By using this website, you acknowledge and agree that the use of AI-generated content involves inherent limitations, uncertainties and inaccuracies, and you accept full responsibility for how you interpret and use the information provided.

We reserve the right to modify, update, or remove content and this disclaimer at any time without prior notice.

Source: scanx.trade

Recent News

Aspira Pathlab & Diagnostics Open Offer Concludes: Acquirers Accept 22,82,507 Shares at ₹55 Each
Aspira Pathlab & Diagnostics Open Offer Concludes: Acquirers...

Source: scanx.trade

18 May 2026
High equity taxes dampen market sentiment amid FII outflows, West Asia war: What should investors do?
High equity taxes dampen market sentiment amid FII outflows,...

Source: Livemint

18 May 2026
Biogen Pharmachem Industries Completes Allotment of 15,04,33,833 Bonus Equity Shares
Biogen Pharmachem Industries Completes Allotment of 15,04,33...

Source: scanx.trade

18 May 2026
SpaceX’s mega-IPO puts a price tag on the fear of missing out
SpaceX’s mega-IPO puts a price tag on the fear of missing ou...

Source: The Hindu Business Line

18 May 2026
Vidya Wires Net Profit Rises 55% YoY to ₹196.12 Mn
Vidya Wires Net Profit Rises 55% YoY to ₹196.12 Mn

Source: scanx.trade

18 May 2026
Pri Caf acquires additional 2,75,000 shares in Paisalo Digital on May 18, 2026
Pri Caf acquires additional 2,75,000 shares in Paisalo Digit...

Source: scanx.trade

18 May 2026
Monika Alcobev Announces June 18 Record Date for Final Dividend and AGM Under SEBI Regulation 42
Monika Alcobev Announces June 18 Record Date for Final Divid...

Source: scanx.trade

18 May 2026
Promoter Amitaabh Goenka Acquires 1,09,727 Equity Shares of Premier Polyfilm Limited via Open Market
Promoter Amitaabh Goenka Acquires 1,09,727 Equity Shares of...

Source: scanx.trade

18 May 2026
Pro Fitcch acquires 2.75 lakh shares in Paisalo Digital
Pro Fitcch acquires 2.75 lakh shares in Paisalo Digital

Source: scanx.trade

18 May 2026
Vikas Khemani-backed Q-Line Biotech, the biggest SME IPO of the year, to open on May 21
Vikas Khemani-backed Q-Line Biotech, the biggest SME IPO of...

Source: Moneycontrol

18 May 2026
pre ipo advisory services in India
  • GST No: 07AAHCB7068H2ZF

India IPO is a leading Indian business services platform that helps firms and companies to launch their initial public offerings (IPOs) in order to raise essential capital for growth and expansion while adding value & fueling the nation’s immense potential and future opportunities.

Follow us:

Facebook Twitter LinkedIn Instagram YouTube

Quick Links

  • Home
  • Blogs
  • Consultant
  • Youtube Videos
  • News
  • Contact Us
  • Career

Contact Information:

  • Corporate Office: 808, 8th Floor, D-Mall, Netaji Subhash Place, Pitampura, Delhi-110034
  • Regional Office: Office No. 601, Shagun Insignia, Ulwe, Sector-19, Navi Mumbai- 410206
  • Email: info@indiaipo.in
  • Mobile: +91-74283-37280, +91-96509-82781
  • Disclaimer  |
  • Privacy & Policy  |
  • Terms & Conditions  

Copyright © All rights reserved by - Bmarkt Tecamat Private Limited